Corporate
  • Astellas Pharma

    Created in 2005
  • Social networks

    490,821 42,723 42,723
  • Sectors

  • Location

    Nihombashi Astellas Mitsui Bldg., 2-chōme-5-1 Nihonbashihonchō, Chuo City, Tokyo 103-0023, Japan

    Chuo City

    Japan

  • Engaged entities

    84
    57 19
  • Added in Motherbase

    17 Jul 2024, 2:43 p.m.
Description
  • Value proposition

    Astellas Pharma is a pharmaceutical company conducting business in approximately 70 countries around the world.

    At Astellas, we strive to be a cutting-edge, value-driven life science innovator. This means working at the forefront of healthcare change to turn innovative science into the best outcomes for patients. Operating in approximately 70 countries with more than 14,000 employees, we are relentless in our pursuit of scientific progress and in tackling unmet medical needs. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

    Pharmaceuticals and 医薬品

Entity interactions BETA
Entity TypeTweets Articles
Emerging Markets Intelligence & Research | EMIR Emerging Markets Intelligence & Research | EMIR
martech, Research Services
Other

10 Jul 2024


aMoon Fund aMoon Fund
Venture Capital and Private Equity Principals
Other

3 Jul 2024


L'Hôpital Privé du Confluent - Vivalto Santé L'Hôpital Privé du Confluent - Vivalto Santé
healthtech
Other

6 Feb 2024


FRANCE REIN FRANCE REIN
healthtech
Other

31 Dec 2023


Laverock Therapeutics Laverock Therapeutics
biotech, deeptech
Other

10 Apr 2024


RideTandem | B CorpTM RideTandem | B CorpTM
transporttech
Other

27 May 2024


Menopause Reality Menopause Reality
it services
Other

31 Dec 2023


ISTUD Business School ISTUD Business School
Higher Education, edtech
Other

12 Dec 2023


Global Health Innovative Technology (GHIT) Fund Global Health Innovative Technology (GHIT) Fund
deeptech, healthtech, Non-profit Organizations
Other

16 May 2024


Astellas Gene Therapies Astellas Gene Therapies
biotech, deeptech, Biotechnology Research
Other

31 May 2023


Radars
Loading...